Florence Demurger
Vannes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.
Journal: Research square
Published: January 08, 2026
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.
Journal: European journal of neurology
Published: November 23, 2025
De novo variants in ATP2B1 lead to neurodevelopmental delay.
Journal: American journal of human genetics
Published: November 12, 2025
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study.
Journal: European journal of neurology
Published: May 20, 2025
The Clinical and Genetic Landscape of a French Multicenter Cohort of 2563 Epilepsy Patients Referred for Genetic Diagnosis.
Journal: European journal of neurology
Published: April 22, 2025
Heterozygous loss-of-function variants in SPTAN1 cause an early childhood onset distal myopathy.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 15, 2024
Heterozygous loss-of-function variants in SPTAN1 cause a novel early childhood onset distal myopathy with chronic neurogenic features.
Journal: medRxiv : the preprint server for health sciences
Published: October 07, 2024
Prenatal diagnosis of mucopolysaccharidosis type I on hepatosplenomegaly and coarse features: a case-report.
Journal: BMC pregnancy and childbirth
Published: September 02, 2024
An AluYa5 Insertion in the 3'UTR of COL4A1 and Cerebral Small Vessel Disease.
Journal: JAMA network open
Published: April 17, 2024
Biallelic EPB41L3 variants underlie a developmental disorder with seizures and myelination defects.
Journal: Brain : a journal of neurology
Published: March 14, 2024
Last Updated: 09/26/2026